Kawai, Shoko
Watanabe, Kageaki
Asai, Maiko
Hashimoto, Kana
Hakozaki, Taiki
Narita, Kosuke
Yomota, Makiko
Hosomi, Yukio https://orcid.org/0000-0002-3849-5905
Article History
Received: 26 October 2020
Accepted: 1 January 2021
First Online: 3 March 2021
Compliance with ethical standards
:
: Dr. Hosomi reports personal fees from AstraZeneca, personal fees from Eli Lilly Japan, personal fees from Taiho Pharmaceutical, personal fees from Chugai Pharmaceutical, personal fees from Ono Pharmaceutical, personal fees from Bristol-Myers Squibb, personal fees from Kyowa Kirin, personal fees from CSL Behring, outside the submitted work; Dr. Yomota reports personal fees from Chugai Pharmaceutical, personal fees from Ono Pharmaceutical, personal fees from AstraZeneca plc, personal fees from Kyowa Kirin, outside the submitted work; Dr. Watanabe reports personal fees from MSD, personal fees from Chugai Pharmaceutical, personal fees from Ono Pharmaceutical, personal fees from AstraZeneca, personal fees from Taiho Pharmaceutical, personal fees from Pfizer, personal fees from Boehringer Ingelheim, outside the submitted work.